December 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreNovember 01, 2025
According to market estimations the in vitro lung model market to rise from $432.76 million in 2025 to $943.61 million by 2030. North America, having dominated the market with a 45.1% share in 2023, will continue to be a key player, while the pharmaceutical and biotechnology companies segment remains dominant in terms of end-use....
November 01, 2025
According to market projections, the global multiplex detection immunoassay market, valued at USD 2.82 billion in 2024, is anticipated to reach USD 7.81 billion by 2034, growing at a CAGR of 9.75% over the next decade. The increasing research in genomics, proteomics, biopharmaceuticals, and clinical diagnostics drives the market....
November 01, 2025
Market insights predict, the in vitro diagnostics industry is expected to grow from USD 81.47 billion in 2024 to USD 123.45 billion by 2034, driven by a CAGR of 4.45%. With the growing number of people and various diseases, the need for in vitro diagnostics has grown, and it is expected that the demand for in vitro diagnostics will continue in the ...
November 01, 2025
According to forecasts, the global organoids market will grow from USD 69.90 million in 2024 to USD 381.7 million by 2034, with an expected CAGR of 18.5%. Organoids are in high demand because they can replicate the in vivo environment of human organs or the body up to a certain extent, which helps in better analysis and understanding of therapeutic...
November 01, 2025
According to market projections, the companion diagnostic technologies sector is expected to grow from USD 3.10 billion in 2024 to USD 9.06 billion by 2034, reflecting a CAGR of 11.34%. The increasing demand for personalized medicines, rising incidences of cancer and other chronic disorders, and technological advancements drive the market....
November 01, 2025
The immunodiagnostics market is growing with innovations like ELISA, CLIA, and fluorescent immunoassays. The National Institute of Biologicals and regulatory bodies oversee quality and safety for diagnostics, while companies like Thermo Fisher and Serum Institute advance solutions for disease detection and research....
November 01, 2025
The C-reactive protein (CRP) test measures inflammation levels in the body, aiding in diagnosing conditions like infections, autoimmune disorders, and heart disease risk. Demand is growing due to aging populations and advanced technologies. Innovations include rapid, sensitive point-of-care CRP tests....
November 01, 2025
Cardiac biomarkers like troponin, CK, and myoglobin help diagnose heart attacks by detecting damage to the heart. As heart disease rises globally, the demand for these tests increases, aiding early diagnosis and reducing healthcare costs. Recent innovations include Mindray's advanced troponin test and funding for heart disease detection tech....
November 01, 2025
The exosome diagnostic and therapeutic market focuses on innovative research for diagnosing health disorders and monitoring treatments. Exosomes, found in body fluids, are used in cancer therapy, immune modulation, and drug delivery. Companies like Capricor Therapeutics advance exosome-based treatments....
November 01, 2025
Cervical cancer is caused by HPV infections and diagnosed through tests like Pap tests, HPV tests, biopsies, and imaging. Regular screenings and advancements in diagnostic techniques are driving market growth. Initiatives like the WHO’s Global Strategy and investments, such as DNA Wellness' 100 labs, are boosting awareness and detection effor...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com